{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T03:59:12Z","timestamp":1649217552943},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,7,1]],"date-time":"2007-07-01T00:00:00Z","timestamp":1183248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1016\/j.mcna.2007.04.003","type":"journal-article","created":{"date-parts":[[2007,7,19]],"date-time":"2007-07-19T11:18:37Z","timestamp":1184843917000},"page":"729-749","source":"Crossref","is-referenced-by-count":3,"title":["New Trials and Therapies for Acute Myocardial Infarction"],"prefix":"10.1016","volume":"91","author":[{"given":"Richard J.","family":"Gumina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2007.04.003_bib1","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jacc.2004.07.002","article-title":"ACC\/AHA guidelines for the management of patients with ST-elevation myocardial infarction","volume":"44","author":"Antman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib2","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1161\/circ.104.22.2632","article-title":"Time is myocardium and time is outcomes","volume":"104","author":"Gibson","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2007.04.003_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"Keeley","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2007.04.003_bib4","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.amjcard.2005.01.083","article-title":"Relation of interhospital delay and mortality in patients with ST-segment elevation myocardial infarction transferred for primary coronary angioplasty","volume":"95","author":"De Luca","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.CIR.0000121424.76486.20","article-title":"Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: every minute of delay counts","volume":"109","author":"De Luca","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2007.04.003_bib6","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.ehj.2004.03.021","article-title":"Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty","volume":"25","author":"De Luca","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mcna.2007.04.003_bib7","series-title":"Rationale and lexicon of primary angioplasty","author":"Cantor","year":"2002"},{"key":"10.1016\/j.mcna.2007.04.003_bib8","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMoa050849","article-title":"Rescue angioplasty after failed thrombolytic therapy for acute myocardial infarction","volume":"353","author":"Gershlick","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2007.04.003_bib9","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1001\/jama.260.19.2849","article-title":"Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group","volume":"260","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2007.04.003_bib10","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bmj.302.6776.555","article-title":"SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group","volume":"302","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/j.mcna.2007.04.003_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0140-6736(88)91062-8","article-title":"Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty","volume":"1","author":"Simoons","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2007.04.003_bib12","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM198709033171001","article-title":"A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction","volume":"317","author":"Topol","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2007.04.003_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jacc.2005.04.042","article-title":"Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study)","volume":"46","author":"Le May","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.291.8.947","article-title":"Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial","volume":"291","author":"Kastrati","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2007.04.003_bib15","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(06)68147-6","volume":"367","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2007.04.003_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(06)68148-8","article-title":"Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials","volume":"367","author":"Keeley","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2007.04.003_bib17","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.ahj.2003.07.025","article-title":"Facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention: design and rationale of the Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events (FINESSE) trial","volume":"147","author":"Ellis","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.mcna.2007.04.003_bib18","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1001\/jama.293.14.1759","article-title":"Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials","volume":"293","author":"De Luca","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2007.04.003_bib19","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1161\/01.CIR.0000126284.40075.98","article-title":"Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone","volume":"109","author":"Antoniucci","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2007.04.003_bib20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1161\/01.CIR.98.8.734","article-title":"Randomized, placebo-controlled trial of platelet glycoprotein IIb\/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators","volume":"98","author":"Brener","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2007.04.003_bib21","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1056\/NEJM200106213442503","article-title":"Platelet glycoprotein IIb\/IIIa inhibition\u00a0with coronary stenting for acute myocardial infarction","volume":"344","author":"Montalescot","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2007.04.003_bib22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0735-1097(99)00635-X","article-title":"Effect of glycoprotein IIb\/IIIa receptor blockade with abciximab on clinical and angiographic restenosis rate after the placement of coronary stents following acute myocardial infarction","volume":"35","author":"Neumann","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib23","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1161\/01.CIR.0000087601.45803.86","article-title":"Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial","volume":"108","author":"Tcheng","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2007.04.003_bib24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ehj.2004.04.003","article-title":"Facilitation of primary coronary angioplasty by early start of a glycoprotein 2b\/3a inhibitor: results of the ongoing tirofiban in myocardial infarction evaluation (On-TIME) trial","volume":"25","author":"van't Hof","year":"2004","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mcna.2007.04.003_bib25","unstructured":"Gibson C. Time to Integrilin Therapy in Acute Myocardial Infarction (TITAN-TIMI 34) Presented at the AHA Scientific Sessions 2005. Dallas (TX), November 13\u201315, 2005."},{"key":"10.1016\/j.mcna.2007.04.003_bib26","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ahj.2004.03.038","article-title":"Combined Abciximab REteplase Stent Study in acute myocardial infarction (CARESS in AMI)","volume":"148","author":"Di Mario","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.mcna.2007.04.003_bib27","unstructured":"ClinicalTrials.gov. Available at: http:\/\/clinicaltrials.gov\/show\/NCT00306228."},{"key":"10.1016\/j.mcna.2007.04.003_bib28","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(05)67660-X","article-title":"Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2007.04.003_bib29","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1056\/NEJMoa050522","article-title":"Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation","volume":"352","author":"Sabatine","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2007.04.003_bib30","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/jama.294.10.1224","article-title":"Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study","volume":"294","author":"Sabatine","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2007.04.003_bib31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.293.4.427","article-title":"Effects of reviparin, a low-molecular-weight heparin, on mortality, reinfarction, and strokes in patients with acute myocardial infarction presenting with ST-segment elevation","volume":"293","author":"Yusuf","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2007.04.003_bib32","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa060898","article-title":"Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction","volume":"354","author":"Antman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2007.04.003_bib33","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0140-6736(01)06887-8","article-title":"Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial","volume":"358","author":"White","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2007.04.003_bib34","unstructured":"ClincalTrials.gov. Available at: http:\/\/clinicaltrials.gov\/show\/NCT00433966."},{"key":"10.1016\/j.mcna.2007.04.003_bib35","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.295.13.joc60038","article-title":"Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial","volume":"295","author":"Yusuf","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2007.04.003_bib36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa062598","article-title":"Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention","volume":"355","author":"Laarman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2007.04.003_bib37","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa062006","article-title":"Sirolimus-eluting versus uncoated stents in acute myocardial infarction","volume":"355","author":"Spaulding","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mcna.2007.04.003_bib38","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jacc.2007.01.081","article-title":"Randomized trial of Sirolimus-Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI)","volume":"49","author":"Menichelli","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib39","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jama.293.9.1063","article-title":"Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial","volume":"293","author":"Stone","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2007.04.003_bib40","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jacc.2005.04.031","article-title":"X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial","volume":"46","author":"Lefevre","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib41","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/CIRCULATIONAHA.105.545178","article-title":"Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation","volume":"112","author":"Gick","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2007.04.003_bib42","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jacc.2006.03.044","article-title":"Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study","volume":"48","author":"Ali","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib43","first-page":"32c","article-title":"Rheolytic thrombectomy in acute myocardial infarction: the Florence experience and objectives of the multicenter randomized JETSTENT trial","volume":"18","author":"Antoniucci","year":"2006","journal-title":"J Invasive Cardiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib44","unstructured":"O'Neill W. Acute Myocardial Infarction With Hyperoxemic Therapy (AMIHOT): a prospective, randomized, multicenter trial. Presented at the Annual Scientific Session of the American College of Cardiology. New Orleans (Louisiana), March 2004."},{"key":"10.1016\/j.mcna.2007.04.003_bib45","unstructured":"ClincalTrials.gov. Available at: http:\/\/clinicaltrials.gov\/show\/NCT00175058."},{"key":"10.1016\/j.mcna.2007.04.003_bib46","unstructured":"Grines C. Intravascular cooling adjunctive to percutaneous coronary intervention for acute myocardial infarction. Presented at the Transcatheter Cardiovascular Therapeutics 2004, Washington, DC, September 2004."},{"key":"10.1016\/j.mcna.2007.04.003_bib47","unstructured":"ClincalTrials.gov. Available at: http:\/\/clinicaltrials.gov\/show\/NCT00248196."},{"key":"10.1016\/j.mcna.2007.04.003_bib48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jama.293.4.437","article-title":"Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial","volume":"293","author":"Mehta","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2007.04.003_bib49","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.jacc.2006.01.040","article-title":"Glucose-insulin-potassium infusion in patients with acute myocardial infarction without signs of heart failure: the Glucose-Insulin-Potassium Study (GIPS)-II","volume":"47","author":"Timmer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib50","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1093\/eurheartj\/ehl304","article-title":"Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: the randomized multicentre CASTEMI study","volume":"27","author":"Bar","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mcna.2007.04.003_bib51","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11239-005-3267-4","volume":"20","author":"Jang","year":"2005","journal-title":"J Thromb Thrombolysis"},{"issue":"Suppl 3","key":"10.1016\/j.mcna.2007.04.003_bib52","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00005344-199206203-00006","article-title":"Cardioprotective effects of nicorandil","volume":"20","author":"Gross","year":"1992","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.mcna.2007.04.003_bib53","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/00005344-198405000-00024","article-title":"Effects of nicorandil and nifedipine on protection of ischemic myocardium","volume":"6","author":"Lamping","year":"1984","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.mcna.2007.04.003_bib54","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/CIRCULATIONAHA.104.530329","article-title":"Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction","volume":"112","author":"Ishii","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2007.04.003_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1253\/circj.68.101","volume":"68","author":"Minamino","year":"2004","journal-title":"Circ J"},{"key":"10.1016\/j.mcna.2007.04.003_bib56","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0735-1097(99)00418-0","article-title":"Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial","volume":"34","author":"Mahaffey","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib57","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2005.02.061","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II)","volume":"45","author":"Ross","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.cardiores.2006.02.014","article-title":"Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2b receptor cascade","volume":"70","author":"Philipp","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.mcna.2007.04.003_bib59","doi-asserted-by":"crossref","first-page":"H579","DOI":"10.1152\/ajpheart.01064.2002","article-title":"Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning","volume":"285","author":"Zhao","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.mcna.2007.04.003_bib60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.cardiores.2006.01.024","article-title":"Postconditioning: reduction of reperfusion-induced injury","volume":"70","author":"Zhao","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.mcna.2007.04.003_bib61","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1161\/CIRCULATIONAHA.105.558122","article-title":"Postconditioning the human heart","volume":"112","author":"Staat","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2007.04.003_bib62","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1161\/01.CIR.0000087447.12918.85","article-title":"Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial","volume":"108","author":"Granger","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2007.04.003_bib63","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1161\/01.CIR.100.25.2499","article-title":"Pharmacology and biological efficacy of a recombinant, humanized, single-chain antibody C5 complement inhibitor in patients undergoing coronary artery bypass graft surgery with cardiopulmonary bypass","volume":"100","author":"Fitch","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.mcna.2007.04.003_bib64","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.297.1.43","article-title":"Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial","volume":"297","author":"APEX AMI Investigators:","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2007.04.003_bib65","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2007.04.003_bib66","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/14628840304611","article-title":"Clinical introduction of the Tandemheart, a percutaneous left ventricular assist device, for circulatory support during high-risk percutaneous coronary intervention","volume":"5","author":"Vranckx","year":"2003","journal-title":"Int J Cardiovasc Intervent"},{"key":"10.1016\/j.mcna.2007.04.003_bib67","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ahj.2006.05.031","article-title":"A randomized multicenter clinical study to evaluate the safety and efficacy of the tandemHeart percutaneous ventricular assist device versus conventional therapy with intraaortic balloon pumping for treatment of cardiogenic shock","volume":"152","author":"Burkhoff","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.mcna.2007.04.003_bib68","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/eurheartj\/ehi161","article-title":"Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock","volume":"26","author":"Thiele","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mcna.2007.04.003_bib69","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","article-title":"Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial","volume":"360","author":"Follath","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2007.04.003_bib70","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1053\/euhj.2001.3158","article-title":"Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN)","volume":"23","author":"Moiseyev","year":"2002","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mcna.2007.04.003_bib71","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1177\/0091270004273849","article-title":"Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST elevation myocardial infarction: a series of cases","volume":"45","author":"Garc\u00eda-Gonz\u00e1lez","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.mcna.2007.04.003_bib72","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.jacc.2004.02.052","article-title":"The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia","volume":"43","author":"Sonntag","year":"2004","journal-title":"J Am Coll Cardiol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712507000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712507000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T09:19:42Z","timestamp":1556702382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712507000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["S0025712507000454"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2007.04.003","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}